REPORT ID 14025

Global Glucagon Market Research Report 2017

Publish Date
23-Nov-17
Pages
116
Format
Electronic (PDF)

This report studies the Glucagon market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Glucagon market by product type and applications/end industries.

In the last several years, global market of glucagon developed rapidly, with an average growth rate of 5.38%. In 2016, global revenue of glucagon is nearly 408 M USD; the actual consumption is about 22.9 million units.

The major players in global Glucagon market include 
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth rate (%) of glucagon in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Glucagon market is primarily split into 
Inject Glucagon
Nasal Glucagon


On the basis on the end users/applications, this report covers 
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others

 
 
			   
Table of Contents

1 Glucagon Market Overview	1
1.1 Glucagon Product Overview	1
1.2 Glucagon Segment by Types (Product Category)	2
1.2.1 Global Glucagon Sales and Growth (%) Comparison by Types (2012-2022)	2
1.2.2 Inject Glucagon	3
1.2.3 Nasal Glucagon	3
1.3 Global Glucagon Segment by Applications	4
1.3.1 Global Glucagon Sales (K Unit) Comparison by Applications (2012-2022)	4
1.3.2 Hypoglycemia	5
1.3.3 Cardiogenic Shock	6
1.4 Global Glucagon Market by Regions (2012-2022)	7
1.4.1 Global Glucagon Market Size and Growth Rate Comparison by Regions (2012-2022)	7
1.4.2 North America Glucagon Status and Prospect (2012-2022)	8
1.4.3 Europe Glucagon Status and Prospect (2012-2022)	9
1.4.4 Asia-Pacific Glucagon Status and Prospect (2012-2022)	10
1.4.5 South America Glucagon Status and Prospect (2012-2022)	11
1.4.6 Middle East and Africa Glucagon Status and Prospect (2012-2022)	12
1.5 Global Glucagon Market Size (2012-2022)	13
1.5.1 Global Glucagon Revenue Status and Outlook (2012-2022)	13
1.5.2 Global Glucagon Sales Status and Outlook (2012-2022)	14
2 Global Glucagon Market Competition by Manufacturers/Brand	15
2.1 Global Glucagon Sales and Share by Manufacturers	15
2.2 Global Glucagon Revenue and Share by Manufacturers (2016-2017)	17
2.3 Global Glucagon Average Price by Manufacturers (2016-2017)	19
2.4 Manufacturers Glucagon Manufacturing Established Date and Headquarters	20
2.5 Glucagon Market Competitive Situation and Trends	21
2.5.1 Glucagon Market Concentration Rate	21
2.5.2 Glucagon Revenue Market Share of Top 3 Manufacturers	22
2.5.3 Mergers & Acquisitions, Expansion	22
3 Global Glucagon Sales, Revenue by Regions (2012-2017)	26
3.1 Global Glucagon Sales and Market Share by Regions (2012-2017)	26
3.2 Global Glucagon Revenue and Market Share by Regions (2012-2017)	28
3.3 Global Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)	30
3.4 North America Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)	30
3.5 Europe Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)	30
3.6 Asia-Pacific Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)	31
3.7 South America Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)	31
3.8 Middle East and Africa Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)	31
4 Global Glucagon Sales, Revenue, Price Trend by Types	32
4.1 Global Glucagon Sales and Market Share by Types (2012-2017)	32
4.2 Global Glucagon Revenue and Market Share by Types (2012-2017)	32
4.3 Global Glucagon Price by Type (2012-2017)	33
5 Global Glucagon Market Analysis by Applications	34
5.1 Global Glucagon Sales and Market Share by Applications (2012-2017)	34
5.2 Global Glucagon Sales Growth Rate by Applications (2012-2017)	36
6 Analysis of Glucagon Industry Key Manufacturers	37
6.1 Novo Nordisk	37
6.1.1 Company Profile	37
6.1.2 Product Information	38
6.1.3 Sales, Price, Cost, Gross, and Revenue	38
6.2 Eli Lilly	39
6.2.1 Company Profile	39
6.2.2 Product Information	40
6.2.3 Sales, Price, Cost, Gross, and Revenue	40
6.3 Fresenius Kabi	41
6.3.1 Company Profile	41
6.3.2 Product Information	42
6.3.3 Sales, Price, Cost, Gross, and Revenue	42
6.4 Torrent Pharma	43
6.4.1 Company Profile	43
6.4.2 Product Information	44
6.4.3 Sales, Price, Cost, Gross, and Revenue	44
6.5 Taj Pharmaceuticals	45
6.6 Xeris Pharmaceuticals	46
6.6.1 Company Profile	46
6.6.2 Product Information	47
7 Glucagon Manufacturing Cost Analysis	48
7.1 Glucagon Key Component Analysis	48
7.1.1 Key Component	48
7.1.2 Key Suppliers of Raw Materials	48
7.2 Proportion of Manufacturing Cost Structure	50
7.2.1 Raw Materials	50
7.2.2 Labor Cost	50
7.2.3 Other Costs Analysis	57
8 Industrial Chain, Sourcing Strategy and Downstream Buyers	62
8.1 Glucagon Industrial Chain Analysis	62
8.2 Upstream Raw Materials Sourcing	62
8.3 Downstream Buyers	63
9 Marketing Strategy Analysis, Distributors/Traders	66
9.1 Marketing Channel	66
9.1.1 Direct Marketing	66
9.1.2 Indirect Marketing	66
9.1.3 Marketing Channel Development Trend	66
9.2 Market Positioning	67
9.2.1 Pricing Strategy	67
9.2.2 Brand Strategy	68
9.2.3 Target Client	69
9.3 Distributors/Traders List	70
10 Market Effect Factors Analysis	72
10.1 Technology Progress/Risk	72
10.1.1 Substitutes Threat	72
10.1.2 Technology Progress in Related Industry	72
10.2 Consumer Needs/Customer Preference Change	74
10.3 Economic/Political Environmental Change	74
11 Global Glucagon Market Forecast (2017-2022)	80
11.1 Global Glucagon Sales, Revenue Forecast (2017-2022)	80
11.1.1 Global Glucagon Sales and Growth Rate Forecast (2017-2022)	80
11.1.2 Global Glucagon Revenue and Growth Rate Forecast (2017-2022)	81
11.1.3 Global Glucagon Price and Trend Forecast (2017-2022)	82
11.2 Global Glucagon Sales and Revenue Forecast by Regions (2017-2022)	82
11.2.1 North America Glucagon Sales and Revenue Forecast (2017-2022)	85
11.2.2 Europe Glucagon Sales and Revenue Forecast (2017-2022)	87
11.2.3 Asia-Pacific Glucagon Sales and Revenue Forecast (2017-2022)	89
11.2.4 South America Glucagon Sales and Revenue Forecast (2017-2022)	91
11.2.5 Middle East and Africa Glucagon Sales and Revenue Forecast (2017-2022)	93
11.3 Global Glucagon Sales, Revenue, Price Forecast by Type (2017-2022)	94
11.4 Global Glucagon Sales Forecast by Application (2017-2022)	97
12 Research Findings and Conclusion	99
13 Methodology and Data Source	100
13.1 Methodology/Research Approach	100
13.1.1 Research Programs/Design	100
13.1.2 Market Size Estimation	101
13.1.3 Market Breakdown and Data Triangulation	102
13.2 Data Source	103
13.2.1 Secondary Sources	103
13.2.2 Primary Sources	104
13.3 Disclaimer	105
13.4 Author List	106